Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
Nuwellis, Inc. (NUWE)
Company Research
Source: GlobeNewswire
MINNEAPOLIS, March 10, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Recent Highlights: Fourth quarter revenue of $2.4 million, a 4% increase compared to the prior-year quarter and 9% increase sequentially.208% increase in U.S. console sales in Q4 versus prior year quarter.Heart Failure revenue increased 48% and Pediatrics increased 16% year-over-year in Q4.Gross margin of 68.2% in Q4, compared to 58.4% in the prior-year quarter.Closed a $5.0 million private placement and warrant inducement transaction in January 2026, strengthening the Company's capital position.Appointed Carisa Schultz as Chief Financial Officer, effective February 2, 2026.Executed a definitive stock purchase agreement to acquire Rendiatech, expanding the Company's cardiorenal portfo
Show less
Read more
Impact Snapshot
Event Time:
NUWE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NUWE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NUWE alerts
High impacting Nuwellis, Inc. news events
Weekly update
A roundup of the hottest topics
NUWE
News
- Nuwellis Completes Acquisition of Rendiatech [Yahoo! Finance]Yahoo! Finance
- Nuwellis Completes Acquisition of RendiatechGlobeNewswire
- Nuwellis (NUWE) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy [Yahoo! Finance]Yahoo! Finance
- Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal StrategyGlobeNewswire
NUWE
Earnings
- 5/13/25 - Miss
NUWE
Sec Filings
- 3/17/26 - Form 8-K
- 3/11/26 - Form 10-K
- 3/10/26 - Form 8-K
- NUWE's page on the SEC website